Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G F Ferraccioli

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
Lancet (London, England)|August 15, 1987
Need for acceptable measures of disease progression in rheumatoid arthritisG F Ferraccioli, F Salaffi, P Manganelli
Revista Espanola De Reumatismo Y Enfermedades Osteoarticulares|January 1, 1976
[Critical considerations on the effects of a protease inhibitor]U Ambanelli, G F Ferraccioli, M Maini
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 1, 1997
Risks and benefits of low-dosage cyclosporin in rheumatoid arthritisG Pasero, G F Ferraccioli, I Portioli
Clinical and Experimental Rheumatology|January 1, 1991
Relationship between physical impairment, psychological variables and pain in rheumatoid disability. An analysis of their relative impactF Cavalieri, F Salaffi, G F Ferraccioli
Scandinavian Journal of Rheumatology|January 1, 1982
Serum antioxidant activity and related variables in rheumatoid arthritis. Behaviour during sulphydrylant treatmentU Ambanelli, A Spisni, G F Ferraccioli
Clinical and Experimental Rheumatology|January 1, 1988
Pain language in fibromyalgia, rheumatoid arthritis and osteoarthritisM Nolli, L Ghirelli, G F Ferraccioli
Bollettino Della Societa Italiana Di Biologia Sperimentale|March 15, 1980
[Preparation of samples of biological fluids for electron spin resonance (ESR) examination]D C Giori, G F Ferraccioli, P Bernardi
Reumatismo|July 27, 2010
Mycophenolic acid in rheumatology: mechanisms of action and severe adverse eventsG Zizzo, M De Santis, G F Ferraccioli
Clinical and Experimental Rheumatology|July 1, 1993
Erythropoietin and the anemia of chronic diseasesS De Marchi, M Pirisi, G F Ferraccioli
Annals of the New York Academy of Sciences|August 30, 2005
Rationale for T cell inhibition by cyclosporin A in major autoimmune diseasesG F Ferraccioli, P Tomietto, M De Santis
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Lancet (London, England)|August 15, 1987
Need for acceptable measures of disease progression in rheumatoid arthritisG F Ferraccioli, F Salaffi, P Manganelli
Revista Espanola De Reumatismo Y Enfermedades Osteoarticulares|January 1, 1976
[Critical considerations on the effects of a protease inhibitor]U Ambanelli, G F Ferraccioli, M Maini
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 1, 1997
Risks and benefits of low-dosage cyclosporin in rheumatoid arthritisG Pasero, G F Ferraccioli, I Portioli
Clinical and Experimental Rheumatology|January 1, 1991
Relationship between physical impairment, psychological variables and pain in rheumatoid disability. An analysis of their relative impactF Cavalieri, F Salaffi, G F Ferraccioli
Scandinavian Journal of Rheumatology|January 1, 1982
Serum antioxidant activity and related variables in rheumatoid arthritis. Behaviour during sulphydrylant treatmentU Ambanelli, A Spisni, G F Ferraccioli
Clinical and Experimental Rheumatology|January 1, 1988
Pain language in fibromyalgia, rheumatoid arthritis and osteoarthritisM Nolli, L Ghirelli, G F Ferraccioli
Bollettino Della Societa Italiana Di Biologia Sperimentale|March 15, 1980
[Preparation of samples of biological fluids for electron spin resonance (ESR) examination]D C Giori, G F Ferraccioli, P Bernardi
Reumatismo|July 27, 2010
Mycophenolic acid in rheumatology: mechanisms of action and severe adverse eventsG Zizzo, M De Santis, G F Ferraccioli
Clinical and Experimental Rheumatology|July 1, 1993
Erythropoietin and the anemia of chronic diseasesS De Marchi, M Pirisi, G F Ferraccioli
Annals of the New York Academy of Sciences|August 30, 2005
Rationale for T cell inhibition by cyclosporin A in major autoimmune diseasesG F Ferraccioli, P Tomietto, M De Santis
Pageof 13